HealthMDMA was hyped as a promising treatment for PTSD – what went wrong? For years, it seemed MDMA-assisted therapy would revolutionise PTSD treatment. But poor trial design and alleged misconduct ultimately stopped the treatment from receiving government approval News
CommentTen Trips review: What tripping taught an academic about psychedelics From ketamine in a London kitchen to wachuma in the Colombian Amazon, self-described "douchey forty-nine-year-old psychedelic virgin" and neuropsychologist Andy Mitchell hopes his trips will teach us more about the drugs Culture